Pharmacists at the Frontline: Why the Retail HCP Deserves a New Marketing Strategy
Pharmacists are playing an expanding role in vaccine delivery, chronic care, and therapeutic recommendations—yet most pharma campaigns treat them as an afterthought. This article...
Lead With Access: Why Pharma Campaigns Should Start With Coverage, Not Brand Awareness
Payer-first pharma marketing is transforming how pharmaceutical brands connect with patients and providers. While traditional campaigns often focus on brand awareness or disease education,...
Real-Time Risk: What Safety Bulletins Mean for Omnichannel Brand Perception
In the fast-moving world of healthcare marketing, the ability to respond swiftly and strategically to regulatory updates has never been more important. As the...
Pricing Politics and Pharma Messaging: Preparing Brands for the Post-IRA Landscape
The Inflation Reduction Act (IRA) has sparked one of the most significant transformations in the U.S. pharmaceutical landscape in decades. As pricing negotiations and...
EU Pharma Reform and the Marketing Fallout: Adapting to a New Regulatory Playbook
The EU pharma reform is reshaping how pharmaceutical companies approach innovation, market access, and marketing...
Rethinking Drug Pricing Communication: Communicating Value Beyond the Sticker Price
As public scrutiny and policy shifts continue to focus on pharmaceutical pricing, the list price of a drug often fails to reflect what patients,...
When Pharma Becomes a Punchline: Crisis Readiness in the Misinformation Age
Today, even the most science-backed pharma brands are just one meme or tweet away from a reputational firestorm. Whether it’s a conspiracy theory, a...
Beating the Algorithm: Designing Pharma Content That Gets Seen in AI‑Prioritized Channels
As inboxes, EHRs, and healthcare apps increasingly rely on artificial intelligence to sort and serve content, many pharma marketing messages risk fading into the...
Green is the New Trust: Communicating Sustainability in Pharma Without Greenwashing
Is your pharma brand ready for the green spotlight? As healthcare procurement and public opinion increasingly favor eco-conscious businesses, pharmaceutical companies can no longer...
Rare, Real, and Under-Measured: Marketing Strategy in Data-Poor Disease States
In the world of rare disease pharma marketing, conventional strategies often hit a wall. Traditional A/B testing and segmentation rely on...
